Mumbai-based Vishat Diagnostics receives ICMR nod for rapid antigen testing kit for COVID-19

Share this News:

Mumbai, 24 July 2020: Home-grown diagnostics company Vishat Diagnostic has received the ICMR approval for its rapid testing antigen kit named as COVID-19 Ag Respi-Strip. The Mumbai-based firm plans to launch the antigen testing kit at an affordable cost of INR 425.

This international standard kit, developed by Belgium’s Coris BioConcept, is also CE approved and is used in several European countries and in North America.

Mr. Pratik Chaitala, Managing Director, Vishat Diagnostics, “At a time when India is touching its peak in daily numbers of cases, it becomes critical to rapidly increase testing. With COVID-19 Ag Respi-Strip, we are bringing CE certified and ICMR approved kits at affordable prices, which is also our company’s driving force for all other product lines. We hope that it will help various state governments to fast pace the testing and isolation process”

So far very few states like Delhi, Uttar Pradesh, and Maharashtra have given nod to rapid antigen testing kits. However, going forward it is anticipated that more and more states will adopt this strategy.

Explaining the technical edge of this kit, Rohit Ramkumar, Technical Head, Vishat Diagnostics, said “COVID-19 Ag Respi-Strip is a patient-centric product. Compared to other kits that need to collect two samples from one patient, our kit needs only one sample and thus has better patient compliance. Other antigen testing kits in the market need a nasal swab which is very inconvenient for the patient. Our kit works with both oral and nasal swabs and is easier on the patient.”. COVID-19 Ag Respi-Strip can show results in a short span of fifteen minutes. If the test is found positive in COVID-19 Ag Respi-Strip there is no need for RT-PCR test. Hence saving cost, time and effort to detect COVID-19 patients.

Founded by Narendra Chitalia in the year 2004, the company offers a wide range of diagnostic products such as Immuno Diagnostic ELISA kits, Radiopharmaceutical kits, Allergens, Cancer Markers, Automated Analyzers, Serology Markers, Immuno reagent kits, Radioisotopes, Reproductive hormones, Tumor Markers, Cytokines and Kits to test Thyroid, and Diabetes.

It also provides diagnostic products for Kidney, Calcium-phosphorus Metabolism, the Cardiovascular, Digestive System, Quantitative recombinant antigens, all Salmonella/Brucella/Proteus products, POCT Immunofluorescence quantitative Analyzers, veterinary diagnostic products, allergens, TORCH markers, Hepatitis markers, products such as Microplate reader and washer, monoclonal and polyclonal antibodies.

It has global business partners all over such as the USA, UK, Canada, Germany, Finland, Italy, China and Korea.